Dihydrothiazine prodrugs of thiazolium agents

Provided are compounds of the formula (and pharmaceutically acceptable salts thereof): wherein: Also provided are pharmaceutical compositions containing the compounds, and methods for the preparation of the compounds. The compounds are useful, among other things, as prodrugs which can be converted u...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Reinhard, Emily, Katten, Elliot
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Reinhard, Emily
Katten, Elliot
description Provided are compounds of the formula (and pharmaceutically acceptable salts thereof): wherein: Also provided are pharmaceutical compositions containing the compounds, and methods for the preparation of the compounds. The compounds are useful, among other things, as prodrugs which can be converted under acidic conditions to thiazolium agents. The compounds can be administered to mammals, including humans, for treatment of various indications.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07511036</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07511036</sourcerecordid><originalsourceid>FETCH-uspatents_grants_075110363</originalsourceid><addsrcrecordid>eNrjZNB1ycyoTCnKL8nITKzKzEtVKCjKTykqTS9WyE9TAAvm52SW5iokpqfmlRTzMLCmJeYUp_JCaW4GBTfXEGcP3dLigsQSkIr49KJEEGVgbmpoaGBsZkyEEgDr_Suy</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Dihydrothiazine prodrugs of thiazolium agents</title><source>USPTO Issued Patents</source><creator>Reinhard, Emily ; Katten, Elliot</creator><creatorcontrib>Reinhard, Emily ; Katten, Elliot ; Synvista Therapeutics, Inc</creatorcontrib><description>Provided are compounds of the formula (and pharmaceutically acceptable salts thereof): wherein: Also provided are pharmaceutical compositions containing the compounds, and methods for the preparation of the compounds. The compounds are useful, among other things, as prodrugs which can be converted under acidic conditions to thiazolium agents. The compounds can be administered to mammals, including humans, for treatment of various indications.</description><language>eng</language><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7511036$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7511036$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Reinhard, Emily</creatorcontrib><creatorcontrib>Katten, Elliot</creatorcontrib><creatorcontrib>Synvista Therapeutics, Inc</creatorcontrib><title>Dihydrothiazine prodrugs of thiazolium agents</title><description>Provided are compounds of the formula (and pharmaceutically acceptable salts thereof): wherein: Also provided are pharmaceutical compositions containing the compounds, and methods for the preparation of the compounds. The compounds are useful, among other things, as prodrugs which can be converted under acidic conditions to thiazolium agents. The compounds can be administered to mammals, including humans, for treatment of various indications.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZNB1ycyoTCnKL8nITKzKzEtVKCjKTykqTS9WyE9TAAvm52SW5iokpqfmlRTzMLCmJeYUp_JCaW4GBTfXEGcP3dLigsQSkIr49KJEEGVgbmpoaGBsZkyEEgDr_Suy</recordid><startdate>20090331</startdate><enddate>20090331</enddate><creator>Reinhard, Emily</creator><creator>Katten, Elliot</creator><scope>EFH</scope></search><sort><creationdate>20090331</creationdate><title>Dihydrothiazine prodrugs of thiazolium agents</title><author>Reinhard, Emily ; Katten, Elliot</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_075110363</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Reinhard, Emily</creatorcontrib><creatorcontrib>Katten, Elliot</creatorcontrib><creatorcontrib>Synvista Therapeutics, Inc</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Reinhard, Emily</au><au>Katten, Elliot</au><aucorp>Synvista Therapeutics, Inc</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Dihydrothiazine prodrugs of thiazolium agents</title><date>2009-03-31</date><risdate>2009</risdate><abstract>Provided are compounds of the formula (and pharmaceutically acceptable salts thereof): wherein: Also provided are pharmaceutical compositions containing the compounds, and methods for the preparation of the compounds. The compounds are useful, among other things, as prodrugs which can be converted under acidic conditions to thiazolium agents. The compounds can be administered to mammals, including humans, for treatment of various indications.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_07511036
source USPTO Issued Patents
title Dihydrothiazine prodrugs of thiazolium agents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T23%3A51%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Reinhard,%20Emily&rft.aucorp=Synvista%20Therapeutics,%20Inc&rft.date=2009-03-31&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07511036%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true